Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Caravelle International (CACO) Announces Up to $6.8M Private Placement
-
Caravelle International Group Announces a Private Placement of up to $6.8 Million
-
Society Pass (SOPA) Issues Q1 Shareholder Update
-
Society Pass Inc. (Nasdaq: SOPA) 1Q 2024 Shareholder Update and Analyst Recommendations
-
Cloud DX Signs 6-Figure Contract to Design New Wearable; Company Will Present at a Webinar and 4 Investor Conferences
-
HEALWELL AI to Participate in Upcoming Investor Conferences
-
Avenue Therapeutics (ATXI) Enters Warrant Exercise Transactions for $5.0M in Proceeds
-
Avenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds
-
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
-
Starco Brands Partners with B2i Digital to Enhance Shareholder Communication
-
Starco Brands Partners with B2i Digital to Enhance Shareholder Communication
-
B2i Digital is a Gold Sponsor and Provides Marketing Support for Maxim Group’s 2024 Healthcare IT Virtual Conference
-
Meihua International (MHUA) Announces Initial $6M Tranche of Potential $50.5M Maximum Offering
-
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
-
PSI Group, a Long-Established Global Logistics Service Provider, Plans to List on Nasdaq Through Merger with AIB Acquisition Corporation
-
Karuna Therapeutics cut by analysts following news of Bristol-Myers Squibb acquisition
-
Moleculin (MBRX) Prices 7.04M Share Offering at $0.64/sh
-
Moleculin Announces Pricing of $4.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market
-
LE Worldwide Limited Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
-
LE Worldwide Limited Engages B2i Digital to Deploy Cutting-Edge Investor Engagement Campaign
-
ReShape Lifesciences Inc. (RSLS) Engages Maxim Group to Identify Strategic M&A Partnership Alternatives
-
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
-
ReShape Lifesciences® Engages Maxim Group LLC To Identify Strategic M&A Partnership Alternatives
-
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common Stock
-
Green Giant Inc. (GGE) Prices $5.95M Offering
-
Green Giant Inc. Announces Pricing of Public Offering
-
Milestone Scientific (MLSS) Prices 4.765M Share Offering at $0.63/sh
-
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
-
Green Giant (GGE) Announces Proposed Public Offering
-
Green Giant Inc. Announces Proposed Public Offering
-
Milestone Scientific (MLSS) Announces Proposed Public Offering of Common Stock
-
Milestone Scientific Inc. Announces Proposed Public Offering of Common Stock
-
Biolase (BIOL) Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Bit Brother (BETS) Announces Pricing of $12.0 Million Registered Direct Offering
-
Bit Brother Limited Announces Pricing of $12.0 Million Registered Direct Offering
-
NuZee, Inc. Announces Full Exercise and Closing of Over-Allotment Option in Connection with its Underwritten Public Offering
-
DealFlow Events Announces The Microcap Conference for January 2024
-
Dolphin Entertainment, Inc. Announces Partial Exercise and Closing of Over-Allotment Option in Connection with its Underwritten Public Offering
-
POET Technologies Announces Closing of US$1.6 Million Underwritten Public Offering of Common Shares and Warrants
-
DealFlow Events Announces The Microcap Conference for January 2024
-
POET Technologies Inc (POET) Announces Pricing of US$1.4 Million Underwritten Public Offering of Common Shares and Warrants
-
POET Technologies Announces Pricing of US$1.4 Million Underwritten Public Offering of Common Shares and Warrants
-
reAlpha Announces Closing of $8.0 Million Public Offering
-
Agile Therapeutics Posts Growth In Third Quarter Results, Reiterates Confidence In Target of $25M Net Revenue, Positive Cash Flow In 2024
-
Society Pass Inc (Nasdaq: SOPA): Maxim Issues 3Q 2023 Equity Research Update; Maintains Positive Outlook on Organic Growth & M&A
-
DayDayCook Announces Closing of Initial Public Offering
-
reAlpha Tech Corp (AIRE) Prices 1.6M Unit Offering at $5/sh
-
reAlpha Announces Pricing of $8.0 Million Public Offering
-
ReShape Lifesciences (RSLS) Enters Warrant Exercise Transaction for $1.2M in Gross Proceeds

